Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review

MLA

Soghra Rabizadeh, et al. “Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review.” International Journal of Endocrinology and Metabolism, vol. 17, no. 2, Sept. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....933fba77f835fc41004d3303204bd63e&authtype=sso&custid=ns315887.

APA

Soghra Rabizadeh, Manouchehr Nakhjavani, & Alireza Esteghamati. (2018). Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review. International Journal of Endocrinology and Metabolism, 17(2).

Chicago

Soghra Rabizadeh, Manouchehr Nakhjavani, and Alireza Esteghamati. 2018. “Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review.” International Journal of Endocrinology and Metabolism 17 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....933fba77f835fc41004d3303204bd63e&authtype=sso&custid=ns315887.